Yixing Jiang - Concepedia

Author

Yixing Jiang

Penn State Milton S. Hershey Medical Center ORCID

Also Known As

Fa-Chyi Lee, Francis Arena, Judith Clements, Milind Javle, Y Jiang, Y. Jiang, YIXING JIANG, Yi-Xing Jiang, Yixing Jiang

122

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Penn State Milton S. Hershey Medical Center University of Maryland, Baltimore The University of Texas MD Anderson Cancer Center Pennsylvania State University National Cancer Institute

About

Yixing Jiang is an author at Penn State Milton S. Hershey Medical Center specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	27	1.4K
2	Health Sciences	3	3	50
3	Engineering	1	1	65
4	Biomedical Engineering	1	1	23
5	Biomolecular Engineering	1	1	65

Yixing Jiang

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study James J. Harding, Jia Fan, Do‐Youn Oh, The Lancet Oncology MedicineBiliary CancerPathologyPharmacotherapyCancer Treatment	2023	201
c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma Hanning You, Wei Ding, Hien Dang, Hepatology	2011	185
Association of elevated GRP78 expression with increased lymph node metastasis and poor prognosis in patients with gastric cancer Jun Zhang, Yixing Jiang, Zhiliang Jia, Clinical & Experimental Metastasis Grp78 ExpressionGastrointestinal OncologyMedicineImmunologyGastroenterology	2006	184
Phase III study of maintenance gemcitabine (G) and best supportive care (BSC) versus BSC, following standard combination therapy with gemcitabine-carboplatin (G-Cb) for patients with advanced non-small cell lung cancer (NSCLC). Chandra P. Belani, David Waterhouse, Hassan Ghazal, Journal of Clinical Oncology Advanced NsclcOncologyCancer ManagementMaintenance GemcitabineMaintenance Therapy	2010	98
Stat3 Plays an Important Role in Oncogenic Ros- and Insulin-like Growth Factor I Receptor-induced Anchorage-independent Growth Cong S. Zong, Liyu Zeng, Yixing Jiang, Journal of Biological Chemistry	1998	91
Survival Outcomes of Patients with Colorectal Liver Metastases Following Hepatic Resection or Ablation in the Era of Effective Chemotherapy Mehrdad Nikfarjam, Serene Shereef, Eric T. Kimchi, Annals of Surgical Oncology Effective ChemotherapySurgical OncologySurvival OutcomesHepatologyGastrointestinal Oncology	2008	89
Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene Joseph D. Buxbaum, L. Georgieva, James Young, Molecular Psychiatry Implicates Ptprz1PsychiatryMolecular DissectionPsychiatric GeneticsSchizophrenia	2002	86
Nanoliposomal ceramide prevents in vivo growth of hepatocellular carcinoma Hephzibah Rani S. Tagaram, Nicole A. DiVittore, Brian M. Barth, Gut	2010	82
Protein Kinase C-δ Is an Important Signaling Molecule in Insulin-Like Growth Factor I Receptor-Mediated Cell Transformation Weiqun Li, Yixing Jiang, Jiachang Zhang, Molecular and Cellular Biology Important Signaling MoleculeCytoskeletonCell GrowthProtein Kinase C-δInsulin Signaling	1998	77
A high expression level of insulin-like growth factor I receptor is associated with increased expression of transcription factor Sp1 and regional lymph node metastasis of human gastric cancer Yixing Jiang, Liwei Wang, Weida Gong, Clinical & Experimental Metastasis Gastrointestinal OncologyHigh Expression LevelPathologyHuman Gastric CancerTranscription Factor Sp1	2005	75

Page 1